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Successful Fat Grafting in a Patient With
Thromboangiitis Obliterans
Ilenia D’Alessio, MD; Alberto M. Settembrini, MD; Silvia Romagnoli, MD; Gabriele Di Luca, MD;
Maurizio Domanin, MD; and Livio Gabrielli, MD
ABSTRACT
Thromboangiitis obliterans, or Buerger disease, is a rare
nonatherosclerotic segmental inflammatory vasculitis that generally
affects young tobacco smokers. Although no surgical treatment is
available, the most effective way to halt the disease's progress is
smoking cessation. In this case report, a 29-year-old smoker showed
up to emergency department with gangrene of his fifth left toe and
extensive plantar ulceration. After investigative angiography, he was
diagnosed with Buerger disease. On November 2017, he underwent
fifth left toe amputation and hyperbaric therapy. Five months after
amputation, the patient was rehospitalized because of surgical
wound dehiscence, wide ulceration, and pain. He was treated with
lipofilling using the Coleman technique. Two weeks after the fat
grafting procedure, the patient suspended pain control medication,
and after 2 months, the surgical wound was almost healed. Fat
grafting (lipofilling) is mostly used in plastic surgery; it offers
regenerative effects, with minimal discomfort for the patient. This
case report demonstrates a successful alternative use of lipofilling for
this unique condition and opens up new options for use of this
technique in other fields.
KEYWORDS: Buerger disease, fat grafting, lipofilling, plastic surgery,
smoking, thromboangiitis obliterans, wound care
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INTRODUCTION
Thromboangiitis obliterans, also known as Buerger disease, is a
nonatherosclerotic segmental inflammatory disease of the small
and medium arteries that mainly affects males younger than
45 years with a current or recent history of tobacco use. The im-
mune system and inflammation have been implicated in Buerger
disease pathogenesis. This condition typically presents with dam-
age to the leg arteries and severe distal ischemia, with the integ-
rity of the proximal part of the femoropopliteal axis and no
autoimmune and/or hypercoagulable status.1
The treatment of Buerger disease is usually conservative, with
cycles of prostanoids, antiplatelet drugs, nitric oxide agents, or
bosentan.2 Surgery is used in rare cases when distal target vessels
are available.However, failed bypass occlusion can result in devastat-
ing outcomes such as critical limb ischemia; therefore, surgery is not
usually recommended. Smoking cessation can slow the progression
of symptoms or slightly improve the clinical situation.
Despite general medical advancement, little progress has been
made in terms of treatment for patients affected by Buerger dis-
ease; few data exist on the use of intra-arterial thrombolytic ther-
apy, prostaglandin therapy, or angiogenesis. That said, there is a
growing interest in the use of fat grafting, not only as cosmetic
therapy in plastic surgery, but also as a procedure with enormous
regenerative potential. Adipose tissue is full of stem cells and, if
properly processed, can be used to manage relapsing wounds
such as those seen in patients with Buerger disease.3,4 Although
the true mechanism of recovery is still unknown, many re-
searchers consider fat grafting capable of healing complex wounds
via autologous adipose tissue-derived cell (ATDC) fractions.5
CASE REPORT
The research described in this report was conducted in accordance
with the Declaration of Helsinki. The patient gave informed con-
sent for the study and the publication of this report and
associated images.
A 29-year-old man with an 8 pack-year smoking history came
to the authors’ attention inOctober 2017 because of wet gangrene
and necrosis of his fifth left toe and extensive plantar ulceration.
He reported a worsening clinical condition during the previous
2 months, with extension of the necrosis/ulceration and an in-
crease in pain. He had previously undergone cycles of antibiotic
and antifungal treatment in another clinical department without
improvement (Figure 1).
The patient was admitted to the authors’ department for a
comprehensive clinical and diagnostic study. During his hospital-
ization, an ultrasound indicated a normal femoropopliteal artery
district bilaterally, with triphasic Doppler signals along peripheral
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arteries on his right leg. On his left leg, the Doppler signals were
normal for his popliteal artery below the knee and in the proximal
tract of anterior and posterior tibial artery. However, no Doppler
signals were detected in the distal third of the leg or in his foot.
The patient underwent diagnostic angiography to enhance the
clinical picture. Results showed typical patterns of Buerger dis-
ease: corkscrew-shaped collateral vessels, cutoff-type vascular
occlusions, vessels with smooth-lined lamina in noninvolved
arteries, and discontinuous segmental involvement of affected ar-
teries and veins (Figure 2).6
During his hospitalization, the patient underwent immuno-
logic study, but the autoantibody dosage was negative. Cycles
of prostanoids and hyperbaric therapy were carried out, but
they produced limited benefit. The patient also underwent hy-
perbaric therapy for 20 days with no significant results. After
angiography, he was submitted for fifth left toe amputation;
unfortunately, the surgical wound dehisced. The patient was
dischargedwith diagnosis of Buerger disease,materials on smoking
cessation, and instructions to take prescribed antiplatelet and
pain relief medication.
In March 2018, the patient was rehospitalized for a lack of
healing with wide ulceration and the worsening of pain at rest.
This time, he was treated with lipofilling using the Coleman tech-
nique. His abdominal wall was injected with Klein solution (lido-
caine, adrenalin, and saline), and autologous adipose tissue was
harvested using nine-hole harvesting cannulas. The adipose tis-
suewas processed (920g for 3minutes), and only the intermediate
layer containing both the adipose-derived stromal/stem cells and
stromal/vascular cell component was used.5 The terminal branches
of the patient’s leg arteries were mapped to facilitate graft place-
ment. Multiple injections (1 mL each) of the adipose tissue for-
mulation were inoculated 1 cm above the end of the terminal
Figure 1.
PATIENT ANGIOGRAPHY
Angiography shows typical patterns of thromboangiitis (corkscrew collaterals) and progressive
reduction of vascularization.
Figure 2.
DISEASE EVOLUTION
The evolution of the patient’s thromboangiitis with amputation site necrosis and dehiscence.
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branch of the peroneal, anterior, and posterior tibial arteries,
respectively (Figure 3).
The day after the procedure, the patient reported a marked res-
olution of the pain. He was discharged 3 days after the procedure
following relief of his pain and stopped painkillers 15 days later.
After 30 days, the fifth toe’s dehiscence wound showed progres-
sive improvement, and, at 60 days postprocedure, the wound ap-
peared almost healed (Figure 4). The patient was followed up
monthly to start and now visits biannually.
DISCUSSION
Fat grafting was used for the first time in 1893 by Gustav Neuber
to correct an orbital depression and the sequelae of osteomyelitis.7
Today, the Coleman technique is the criterion standard for fat
grafting. It was developed in 1994, when a team of plastic sur-
geons and researchers demonstrated that fat is the greatest reservoir
of adult mesenchymal stem cells (MSCs) capable of differentiating
into different tissues. Studies3–5 have demonstrated that ATDC
fractions may mediate therapeutic effects through a multitude of
mechanisms that include signaling angiogenesis, inflammation,
cell homing, and cell survival.
Modern literature describes the use of fat grafting in many
fields: in oncologic surgery to reconstruct breast after tumor exci-
sion,8 in the treatment of scars9,10 or burned skin,11 and in pa-
tients with scleroderma or Dupuytren disease.12 Recent studies
have demonstrated the utility of adipose-derived stem cells in
wound healing, describing their ability to regenerate soft tissues
and their remodeling capacity provided by cytokine and growth
Figure 3.
MAPPING AREAS FOR INJECTION CLOSE TO PRINCIPAL
ARTERIES
Figure 4.
ULCER HEALING
A,The ulcer at the end of the procedure. B, 3 months postprocedure.
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factor profiles.13 For example, the literature describes local intra-
muscular injections of autologous or allogeneic MSC that result
in significant regression of skin ulcers and improvements in pain
at rest, Walking Impairment Questionnaire scores, and patient
quality of life.14
To date, there are no published cases of fat grafting used to treat
peripheral arterial disease (PAD) or Buerger disease. Experimental
protocols are studying the use of adipose tissue in peripheral
arteriopathy that is resistant to medical therapy or not surgically
or endovascularly treatable. Other researchers are evaluating the
direct injection of processed centrifuged fat into damaged tissue.
However, there is no published literature about the stimulation
of neoangiogenesis via perivascular stem cell injections.
CONCLUSIONS
The evidence for fat grafting with ATDC or the direct injection of
MSCs to treat Buerger disease or PAD is still anecdotal; only me-
ticulous preclinical and clinical studies can provide more certainty.
Onemajor issue is the lack of data about the long-term survival of
the injected fatty tissue. That said, autologous fat grafting is a
promising field of research in both cosmetic and reconstructive
surgery. This minimally invasive technique may offer some pa-
tients satisfactory clinical results in alleviating signs and symp-
toms, as well as improving their quality of life and reducing
amputations. This case report illustrates the importance of new
methods to treat Buerger disease and, more generally, PAD.•
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